A Trial of CCI-779 in Patients With Soft Tissue Sarcoma.
Phase of Trial: Phase II
Latest Information Update: 03 Jun 2013
At a glance
- Drugs Temsirolimus (Primary)
- Indications Gastrointestinal stromal tumours; Soft tissue sarcoma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 02 Jan 2013 Actual end date changed from Jun 2010 to Dec 2005 as reported by ClinicalTrials.gov.
- 05 May 2011 Status changed from active, no longer recruiting to completed.